Literature DB >> 21985250

Renal elimination of perfluorocarboxylates (PFCAs).

Xing Han1, Diane L Nabb, Mark H Russell, Gerald L Kennedy, Robert W Rickard.   

Abstract

Sex-, species-, and chain length-dependent renal elimination is the hallmark of mammalian elimination of perfluorocarboxylates (PFCAs) and has been extensively studied for almost 30 years. In this review, toxicokinetic data of PFCAs (chain lengths ranging from 4 to 10) in different species are compared with an emphasis on their relevance to renal elimination. PFCAs vary in their affinities to bind to serum albumins in plasma, which is an important factor in determining the renal clearance of PFCAs. PFCA-albumin binding has been well characterized and is summarized in this review. The mechanism of the sex-, species-, and chain length-dependent renal PFCA elimination is a research area that has gained continuous interest since the beginning of toxicological studies of PFCAs. It is now recognized that organic anion transport proteins play a key role in PFCA renal tubular reabsorption, a process that is sex-, species-, and chain length-dependent. Recent studies on the identification of PFCA renal transport proteins and characterization of their transport kinetics have greatly improved our understanding of the PFCA renal transport mechanism at the molecular level. A mathematical representation of this renal tubular reabsorption mechanism has been incorporated in physiologically based pharmacokinetic (PBPK) modeling of perfluorooctanoate (PFOA). Improvement of PBPK models in the future will require more accurate and quantitative characterization of renal transport pathways of PFCAs. To that end, a basolateral membrane efflux pathway for the reabsorption of PFCAs in the kidney is discussed in this review, which could provide a future research direction toward a better understanding of the mechanisms of PFCA renal elimination.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21985250     DOI: 10.1021/tx200363w

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  39 in total

1.  Perfluoroalkyl acids, hyperuricemia and gout in adults: Analyses of NHANES 2009-2014.

Authors:  Franco Scinicariello; Melanie C Buser; Lina Balluz; Kimberly Gehle; H Edward Murray; Henry G Abadin; Roberta Attanasio
Journal:  Chemosphere       Date:  2020-06-20       Impact factor: 7.086

2.  Characterization of non-radiolabeled Thyroxine (T4) uptake in cryopreserved rat hepatocyte suspensions: Pharmacokinetic implications for PFOA and PFOS chemical exposure.

Authors:  Julian Selano; Vicki Richardson; John Washington; Chris Mazur
Journal:  Toxicol In Vitro       Date:  2019-03-28       Impact factor: 3.500

3.  Effects of chronic perfluorooctanoic acid (PFOA) at low concentration on morphometrics, gene expression, and fecundity in zebrafish (Danio rerio).

Authors:  Carrie E Jantzen; Fatima Toor; Kate A Annunziato; Keith R Cooper
Journal:  Reprod Toxicol       Date:  2017-01-29       Impact factor: 3.143

4.  Na+/Taurocholate Cotransporting Polypeptide and Apical Sodium-Dependent Bile Acid Transporter Are Involved in the Disposition of Perfluoroalkyl Sulfonates in Humans and Rats.

Authors:  Wen Zhao; Jeremiah D Zitzow; David J Ehresman; Shu-Ching Chang; John L Butenhoff; Jameson Forster; Bruno Hagenbuch
Journal:  Toxicol Sci       Date:  2015-05-21       Impact factor: 4.849

5.  Longitudinal measures of perfluoroalkyl substances (PFAS) in serum of Gullah African Americans in South Carolina: 2003-2013.

Authors:  Matthew O Gribble; Scott M Bartell; Kurunthachalam Kannan; Qian Wu; Patricia A Fair; Diane L Kamen
Journal:  Environ Res       Date:  2015-03-26       Impact factor: 6.498

6.  Predicting tubular reabsorption with a human kidney proximal tubule tissue-on-a-chip and physiologically-based modeling.

Authors:  Courtney Sakolish; Zunwei Chen; Chimeddulam Dalaijamts; Kusumica Mitra; Yina Liu; Tracy Fulton; Terry L Wade; Edward J Kelly; Ivan Rusyn; Weihsueh A Chiu
Journal:  Toxicol In Vitro       Date:  2019-12-17       Impact factor: 3.500

7.  Hepatic and renal Bcrp transporter expression in mice treated with perfluorooctanoic acid.

Authors:  Lobna M Eldasher; Xia Wen; Michael S Little; Kristin M Bircsak; Lindsay L Yacovino; Lauren M Aleksunes
Journal:  Toxicology       Date:  2013-02-19       Impact factor: 4.221

8.  Perfluoro-octanoic acid impairs sperm motility through the alteration of plasma membrane.

Authors:  I Šabović; I Cosci; L De Toni; A Ferramosca; M Stornaiuolo; A Di Nisio; S Dall'Acqua; A Garolla; C Foresta
Journal:  J Endocrinol Invest       Date:  2019-11-27       Impact factor: 4.256

9.  Perfluoroalkyl substances and thyroid function in older adults.

Authors:  Srishti Shrestha; Michael S Bloom; Recai Yucel; Richard F Seegal; Qian Wu; Kurunthachalam Kannan; Robert Rej; Edward F Fitzgerald
Journal:  Environ Int       Date:  2014-12-05       Impact factor: 9.621

10.  Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages.

Authors:  Anne E Loccisano; Matthew P Longnecker; Jerry L Campbell; Melvin E Andersen; Harvey J Clewell
Journal:  J Toxicol Environ Health A       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.